Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15109
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. The company has operations in Phoenix and San Diego. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp Key Recent Developments

Nov 09,2018: Adamis Pharmaceuticals announces third quarter 2018 financial results and business update
Aug 27,2018: Adamis Pharmaceuticals Provides Business Update
Aug 10,2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update
May 10,2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
Mar 15,2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update

This comprehensive SWOT profile of Adamis Pharmaceuticals Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Adamis Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Adamis Pharmaceuticals Corp – Key Information
Adamis Pharmaceuticals Corp – Overview
Adamis Pharmaceuticals Corp – Key Employees
Adamis Pharmaceuticals Corp – Key Employee Biographies
Adamis Pharmaceuticals Corp – Key Operational Heads
Adamis Pharmaceuticals Corp – Major Products and Services
Adamis Pharmaceuticals Corp – History
Adamis Pharmaceuticals Corp – Company Statement
Adamis Pharmaceuticals Corp – Locations And Subsidiaries
Adamis Pharmaceuticals Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Adamis Pharmaceuticals Corp – Business Description
Adamis Pharmaceuticals Corp – Corporate Strategy
Adamis Pharmaceuticals Corp – SWOT Analysis
SWOT Analysis – Overview
Adamis Pharmaceuticals Corp – Strengths
Adamis Pharmaceuticals Corp – Weaknesses
Adamis Pharmaceuticals Corp – Opportunities
Adamis Pharmaceuticals Corp – Threats
Adamis Pharmaceuticals Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Adamis Pharmaceuticals Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Adamis Pharmaceuticals Corp, Key Information
Adamis Pharmaceuticals Corp, Key Ratios
Adamis Pharmaceuticals Corp, Share Data
Adamis Pharmaceuticals Corp, Major Products and Services
Adamis Pharmaceuticals Corp, History
Adamis Pharmaceuticals Corp, Key Employees
Adamis Pharmaceuticals Corp, Key Employee Biographies
Adamis Pharmaceuticals Corp, Key Operational Heads
Adamis Pharmaceuticals Corp, Other Locations
Adamis Pharmaceuticals Corp, Subsidiaries
Adamis Pharmaceuticals Corp, Key Manufacturing facilities
Adamis Pharmaceuticals Corp, Key Competitors
Adamis Pharmaceuticals Corp, SWOT Analysis
Adamis Pharmaceuticals Corp, Ratios based on current share price
Adamis Pharmaceuticals Corp, Annual Ratios
Adamis Pharmaceuticals Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Adamis Pharmaceuticals Corp, Performance Chart
Adamis Pharmaceuticals Corp, Ratio Charts

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Slavneft-Megionneftegaz (MFGS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Megionneftegaz (Megionneftegaz), a subsidiary of Slavneft, is an oil and gas company that operates oil fields. The company’s activities include appraisal of oil and gas fields, oil and gas production, and well drilling and operation. Megionneftegaz develops and introduces advanced t …
  • Danaher Corp (DHR):企業の財務・戦略的SWOT分析
    Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Chicago Bridge & Iron Company NV (CBI):電力:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …
  • San Leon Energy Plc (SLE):石油・ガス:M&Aディール及び事業提携情報
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • MakeMusic, Inc.:企業の戦略的SWOT分析
    MakeMusic, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Burwill Holdings Limited:企業のM&A・事業提携・投資動向
    Burwill Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Burwill Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Ivoclar Vivadent AG:医療機器:M&Aディール及び事業提携情報
    Summary Ivoclar Vivadent AG (Ivoclar Vivadent) is an international dental products providing company. It manufactures material systems for high quality dental applications. The company’s products include impression materials, adhesives, temporary materials, restorative materials, all-ceramics, lutin …
  • Bonavista Energy Corp (BNP):企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Daiwa Securities Group Inc:戦略・SWOT・企業財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ontario Municipal Employees Retirement System:電力:M&Aディール及び事業提携情報
    Summary Ontario Municipal Employees Retirement System (OMERS) offers pension benefits to government employees, beneficiaries, and retirees from diverse sectors such as municipalities, libraries, police and fire departments, schools, and other agencies in Ontario. It is sponsored by OMERS Sponsors Co …
  • HedgePath Pharmaceuticals Inc (HPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Hedgepath Pharmaceuticals Inc (Hedgepath), a subsidiary of Mayne Pharma Group Ltd, is a clinical stage biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of skin, prostrate, and lung cancers. The company is investigating an oral formula …
  • Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. …
  • Polpharma SA-製薬・医療分野:企業M&A・提携分析
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務情報
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Albertsons Companies, Inc.:戦略・SWOT・企業財務分析
    Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Curemark LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates. Its drug candidate CM-AT is a clinical trial for autism, ADHD, …
  • JSW Steel Ltd:戦略・SWOT・企業財務分析
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Barnes & Noble, Inc.:企業の戦略・SWOT・財務情報
    Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆